Bilirubin new insights into an old molecule Biochemia Medica A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non Alcoholic Fatty Liver Disease Frontiers Glutathione: Pharmacological aspects and implications for clinical use in non alcoholic fatty liver disease Bilirubin, a hepatoprotective agent that activates SIRT1, PGC 1, and PPAR , while inhibiting NF B in rats with metabolic associated fatty liver disease Scientific Reports Guide to Total Bilirubin Levels Levels Dysregulation of glutathione synthesis in liver disease ScienceDirect